<DOC>
	<DOC>NCT00259285</DOC>
	<brief_summary>To determine the response to this regimen for therapy prior surgery in patients with locally advanced disease or metastatic disease.</brief_summary>
	<brief_title>Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Diagnosis of nonsmallcell carcinoma of the lung Patients with locally advanced disease or metastatic disease, candidates to surgery after evaluation by oncologist and thoracic surgeon Tumour with possibility of curative surgery At least one unidimensionally measurable lesion Adequate pulmonary function to perform the planned surgical resection Active infection (at the investigator's discretion) Pregnancy or breastfeeding Serious concomitant illness at the investigator's discretion Previous diagnosis of malignant disease They have received treatment during the last 30 days with a drug, other than the study drug, that has not received regulatory approval for any indication at the time of their entry in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>